Journal of Clinical Psychopharmacology 2000-06-01

Single-dose pharmacokinetics of methylphenidate in CYP2D6 extensive and poor metabolizers.

C L DeVane, J S Markowitz, S W Carson, D W Boulton, H S Gill, Z Nahas, S C Risch

Index: J. Clin. Psychopharmacol. 20(3) , 347-9, (2000)

Full Text: HTML

Abstract

Six adults phenotyped as either extensive (N = 4) or poor (N = 2) metabolizers for cytochrome P450 (CYP) 2D6 were given a 10-mg oral dose of methylphenidate (MPH) on two separate occasions with and without quinidine, a potent CYP2D6 inhibitor. Quinidine had no significant effect on the pharmacokinetics of either MPH or ritalinic acid, its major metabolite, in either group of CYP2D6 metabolizers. These data suggest a lack of involvement of CYP2D6 in the metabolism of MPH. Drugs that are inhibitors of CYP2D6 when taken concurrently with MPH should not affect its plasma concentration.


Related Compounds

Related Articles:

Determination of amphetamine and methylphenidate in exhaled breath of patients undergoing attention-deficit/hyperactivity disorder treatment.

2014-08-01

[Ther. Drug Monit. 36(4) , 528-34, (2014)]

Pharmacological Cognitive Enhancement in Healthy Individuals: A Compensation for Cognitive Deficits or a Question of Personality?

2015-01-01

[PLoS ONE 10 , e0129805, (2015)]

Potential trends in Attention Deficit Hyperactivity Disorder (ADHD) drug use on a college campus: wastewater analysis of amphetamine and ritalinic acid.

2013-04-15

[Sci. Total Environ. 450-451 , 242-9, (2013)]

A safer methylation procedure with boron trifluoride-methanol reagent for gas chromatographic analysis of ritalinic acid in urine.

1992-01-01

[J. Pharm. Biomed. Anal. 10 , 187, (1992)]

Detection of the novel metabolite ethylphenidate after methylphenidate overdose with alcohol coingestion.

1999-08-01

[J. Clin. Psychopharmacol. 19(4) , 362-6, (1999)]

More Articles...